{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:34:51Z","timestamp":1793223291199,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s11916-023-01101-w","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T08:02:54Z","timestamp":1678435374000},"page":"57-63","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Medical Cannabis for Chronic Nonmalignant Pain Management"],"prefix":"10.1007","volume":"27","author":[{"given":"Maha","family":"Hameed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esha","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bekir Nihat","family":"Dogrul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Al-Oleimat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bidushi","family":"Pokhrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selia","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edzel Lorraine","family":"Co","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saloni","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Quinonez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Ruxmohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"key":"1101_CR1","unstructured":"Zelaya CE, Dahlhamer JM, Lucas JW, Connor EM. Chronic pain and high-impact chronic pain among U.S. adults, 2019. NCHS Data Brief. 2020 Nov;(390):1\u20138."},{"key":"1101_CR2","unstructured":"World Health Organization. Opioid overdose [Internet]. 2021 [cited 2022 May 12]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/opioid-overdose"},{"issue":"Suppl 2","key":"1101_CR3","doi-asserted-by":"publisher","first-page":"S215","DOI":"10.21037\/apm.2017.08.05","volume":"6","author":"A Blake","year":"2017","unstructured":"Blake A, Wan BA, Malek L, DeAngelis C, Diaz P, Lao N, et al. A selective review of medical cannabis in cancer pain management. Ann Palliat Med. 2017;6(Suppl 2):S215\u201322.","journal-title":"Ann Palliat Med"},{"issue":"2","key":"1101_CR4","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/MNH.0000000000000590","volume":"29","author":"JL Rein","year":"2020","unstructured":"Rein JL. The nephrologist\u2019s guide to cannabis and cannabinoids. Curr Opin Nephrol Hypertens. 2020;29(2):248\u201357.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"1101_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2105\/AJPH.2018.304593","volume":"109","author":"D Carr","year":"2019","unstructured":"Carr D, Schatman M. Cannabis for chronic pain: not ready for prime time. Am J Public Health. 2019;109(1):50\u20131.","journal-title":"Am J Public Health"},{"key":"1101_CR6","unstructured":"National Conference of State Legislatures. State medical cannabis laws [Internet]. [cited 2022 May 12]. Available from: http:\/\/www.ncsl.org\/research\/health\/state-medical-marijuana-laws.aspx"},{"issue":"5\u20136","key":"1101_CR7","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jpain.2019.09.006","volume":"21","author":"KF Boehnke","year":"2020","unstructured":"Boehnke KF, Scott JR, Litinas E, Sisley S, Williams DA, Clauw DJ. High-frequency medical cannabis use is associated with worse pain among individuals with chronic pain. J Pain. 2020;21(5\u20136):570\u201381.","journal-title":"J Pain"},{"issue":"5","key":"1101_CR8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jogc.2020.08.021","volume":"43","author":"J Manz","year":"2021","unstructured":"Manz J, Hyakutake M, Kelly E. Calling for openness to the study of cannabis use in chronic pelvic pain. J Obstet Gynaecol Can. 2021;43(5):611\u20133.","journal-title":"J Obstet Gynaecol Can"},{"key":"1101_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2021.102720","volume":"59","author":"S Likhitsathian","year":"2021","unstructured":"Likhitsathian S, Edelstein OE, Srisurapanont M, Zolotov Y, Karawekpanyawong N, Reznik A, et al. Cross national comparison of medical students\u2019 attitudes and beliefs about medical cannabis and its application for pain management. Complement Ther Med. 2021;59: 102720.","journal-title":"Complement Ther Med"},{"key":"1101_CR10","doi-asserted-by":"crossref","unstructured":"Gonen T, Amital H. Cannabis and cannabinoids in the treatment of rheumatic diseases. Rambam Maimonides Med J. 2020 Jan 30;11(1).","DOI":"10.5041\/RMMJ.10389"},{"key":"1101_CR11","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Campbell G, Hall WD, Peacock A, Lintzeris N, Bruno R, Larance B, et al. Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study. Lancet Public Health. 2018 Jul;3(7):e341\u201350. This paper highlights the evidence-based statement of chronic nonmalignant pain being the most common reason for cannabis use for medical purposes.","DOI":"10.1016\/S2468-2667(18)30110-5"},{"key":"1101_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.pbb.2015.02.007","volume":"131","author":"P Hasanein","year":"2015","unstructured":"Hasanein P, Teimuri FM. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats. Pharmacol Biochem Behav. 2015;131:130\u20135.","journal-title":"Pharmacol Biochem Behav"},{"issue":"9","key":"1101_CR13","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1080\/00207454.2016.1257992","volume":"127","author":"Y Shang","year":"2017","unstructured":"Shang Y, Tang Y. The central cannabinoid receptor type-2 (CB2) and chronic pain. Int J Neurosci. 2017;127(9):812\u201323.","journal-title":"Int J Neurosci"},{"issue":"3","key":"1101_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ejp.1148","volume":"22","author":"J L\u00f6tsch","year":"2018","unstructured":"L\u00f6tsch J, Weyer-Menkhoff I, Tegeder I. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings. Eur J Pain. 2018;22(3):471\u201384.","journal-title":"Eur J Pain"},{"issue":"3","key":"1101_CR15","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1476-5381.2010.00735.x","volume":"160","author":"EL Scotter","year":"2010","unstructured":"Scotter EL, Abood ME, Glass M. The endocannabinoid system as a target for the treatment of neurodegenerative disease. Br J Pharmacol. 2010;160(3):480\u201398.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1101_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11916-018-0658-8","volume":"22","author":"G Lee","year":"2018","unstructured":"Lee G, Grovey B, Furnish T, Wallace M. Medical cannabis for neuropathic pain. Curr Pain Headache Rep. 2018;22(1):8.","journal-title":"Curr Pain Headache Rep"},{"issue":"Suppl 1","key":"1101_CR17","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1097\/j.pain.0000000000000428","volume":"157","author":"R Maldonado","year":"2016","unstructured":"Maldonado R, Ba\u00f1os JE, Caba\u00f1ero D. The endocannabinoid system and neuropathic pain. Pain. 2016;157(Suppl 1):S23-32.","journal-title":"Pain"},{"issue":"3\u20134","key":"1101_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.prostaglandins.2008.12.002","volume":"89","author":"J Wang","year":"2009","unstructured":"Wang J, Ueda N. Biology of endocannabinoid synthesis system. Prostaglandins Other Lipid Mediat. 2009;89(3\u20134):112\u20139.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"2","key":"1101_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/02791072.2012.684624","volume":"44","author":"P Lucas","year":"2012","unstructured":"Lucas P. Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain. J Psychoactive Drugs. 2012;44(2):125\u201333.","journal-title":"J Psychoactive Drugs"},{"key":"1101_CR20","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M. The endocannabinoid system: physiology and pharmacology. Alcohol Alcohol. 2005 Feb;40(1):2\u201314.","DOI":"10.1093\/alcalc\/agh110"},{"issue":"10","key":"1101_CR21","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s11745-008-3217-y","volume":"43","author":"C Thabuis","year":"2008","unstructured":"Thabuis C, Tissot-Favre D, Bezelgues JB, Martin JC, Cruz-Hernandez C, Dionisi F, et al. Biological functions and metabolism of oleoylethanolamide. Lipids. 2008;43(10):887\u201394.","journal-title":"Lipids"},{"issue":"3\u20134","key":"1101_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.prostaglandins.2009.07.001","volume":"89","author":"G Godlewski","year":"2009","unstructured":"Godlewski G, Offert\u00e1ler L, Wagner JA, Kunos G. Receptors for acylethanolamides-GPR55 and GPR119. Prostaglandins Other Lipid Mediat. 2009;89(3\u20134):105\u201311.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"12","key":"1101_CR23","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.mayocp.2018.09.005","volume":"93","author":"JO Ebbert","year":"2018","unstructured":"Ebbert JO, Scharf EL, Hurt RT. Medical cannabis. Mayo Clin Proc. 2018;93(12):1842\u20137.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"1101_CR24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher P, B\u00e1tkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58(3):389\u2013462.","journal-title":"Pharmacol Rev"},{"issue":"2","key":"1101_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.bjp.0707531","volume":"153","author":"J Guindon","year":"2008","unstructured":"Guindon J, Hohmann AG. Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol. 2008;153(2):319\u201334.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"1101_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","volume":"153","author":"RG Pertwee","year":"2008","unstructured":"Pertwee RG. The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: \u0394 9 -tetrahydrocannabinol, cannabidiol and \u0394 9 -tetrahydrocannabivarin: \u0394 9 -THC, CBD and \u0394 9 -THCV. Br J Pharmacol. 2008;153(2):199\u2013215.","journal-title":"Br J Pharmacol"},{"issue":"10","key":"1101_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11916-015-0524-x","volume":"19","author":"B Jensen","year":"2015","unstructured":"Jensen B, Chen J, Furnish T, Wallace M. Medical marijuana and chronic pain: a review of basic science and clinical evidence. Curr Pain Headache Rep. 2015;19(10):50.","journal-title":"Curr Pain Headache Rep"},{"issue":"4","key":"1101_CR28","doi-asserted-by":"publisher","first-page":"663","DOI":"10.14444\/8087","volume":"15","author":"F Lovecchio","year":"2021","unstructured":"Lovecchio F, Langhans MT, Bennett T, Steinhaus M, Premkumar A, Cunningham M, et al. Prevalence of cannabidiol use in patients with spine complaints: results of an anonymous survey. Int J Spine Surg. 2021;15(4):663\u20138.","journal-title":"Int J Spine Surg"},{"issue":"3","key":"1101_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.55563\/clinexprheumatol\/qcyet7","volume":"39","author":"MA Fitzcharles","year":"2021","unstructured":"Fitzcharles MA, Rampakakis E, Sampalis JS, Shir Y, Cohen M, Starr M, et al. Use of medical cannabis by patients with fibromyalgia in Canada after cannabis legalisation: a cross-sectional study. Clin Exp Rheumatol. 2021;39(3):115\u20139.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"1101_CR30","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s12630-020-01903-1","volume":"68","author":"H Meng","year":"2021","unstructured":"Meng H, Page MG, Ajrawat P, Deshpande A, Samman B, Dominicis M, et al. Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in chronic pain patients. Can J Anesth\/J Can Anesth. 2021;68(5):633\u201344.","journal-title":"Can J Anesth\/J Can Anesth"},{"key":"1101_CR31","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2147\/JPR.S278718","volume":"14","author":"JM Schilling","year":"2021","unstructured":"Schilling JM, Hughes CG, Wallace MS, Sexton M, Backonja M, Moeller-Bertram T. Cannabidiol as a treatment for chronic pain: a survey of patients\u2019 perspectives and attitudes. JPR. 2021;14:1241\u201350.","journal-title":"JPR"},{"key":"1101_CR32","doi-asserted-by":"crossref","unstructured":"Vidot DC, Islam JY, Marlene Camacho-Rivera, Harrell MB, Rao DR, Chavez JV, et al. The COVID-19 cannabis health study: results from an epidemiologic assessment of adults who use cannabis for medicinal reasons in the United States. Journal of Addictive Diseases. 2020 Dec 1;39(1):26\u201336.","DOI":"10.1080\/10550887.2020.1811455"},{"issue":"2","key":"1101_CR33","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/dar.13171","volume":"40","author":"SR Sznitman","year":"2021","unstructured":"Sznitman SR, Vulfsons S, Meiri D, Weinstein G. Medical cannabis and cognitive performance in middle to old adults treated for chronic pain. Drug Alcohol Rev. 2021;40(2):272\u201380.","journal-title":"Drug Alcohol Rev"},{"issue":"9","key":"1101_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-050831","volume":"11","author":"L Zeng","year":"2021","unstructured":"Zeng L, Lytvyn L, Wang X, Kithulegoda N, Agterberg S, Shergill Y, et al. Values and preferences towards medical cannabis among people living with chronic pain: a mixed-methods systematic review. BMJ Open. 2021;11(9): e050831.","journal-title":"BMJ Open"},{"issue":"5","key":"1101_CR35","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1365-2044.2004.03674.x","volume":"59","author":"W Notcutt","year":"2004","unstructured":"Notcutt W, Price M, Miller R, Newport S, Phillips C, Simmons S, et al. Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34\u202f?N of 1? studies. Anaesthesia. 2004;59(5):440\u201352.","journal-title":"Anaesthesia"},{"issue":"11","key":"1101_CR36","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.jpain.2019.05.009","volume":"20","author":"KF Boehnke","year":"2019","unstructured":"Boehnke KF, Scott JR, Litinas E, Sisley S, Clauw DJ, Goesling J, et al. Cannabis use preferences and decision-making among a cross-sectional cohort of medical cannabis patients with chronic pain. J Pain. 2019;20(11):1362\u201372.","journal-title":"J Pain"},{"issue":"7","key":"1101_CR37","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1097\/j.pain.0000000000000899","volume":"158","author":"BJ Piper","year":"2017","unstructured":"Piper BJ, Beals ML, Abess AT, Nichols SD, Martin MW, Cobb CM, et al. Chronic pain patients\u2019 perspectives of medical cannabis. Pain. 2017;158(7):1373\u20139.","journal-title":"Pain"},{"issue":"2","key":"1101_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1300\/J175v03n02_04","volume":"3","author":"R Gallagher","year":"2003","unstructured":"Gallagher R, Best JA, Fyles G, Hawley P, Yeomans W. Attitudes and beliefs about the use of cannabis for symptom control in a palliative population. Journal of Cannabis Therapeutics. 2003;3(2):41\u201350.","journal-title":"Journal of Cannabis Therapeutics"},{"key":"1101_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108610","volume":"193","author":"V Chiu","year":"2021","unstructured":"Chiu V, Leung J, Hall W, Stjepanovi\u0107 D, Degenhardt L. Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA. Neuropharmacology. 2021;193: 108610.","journal-title":"Neuropharmacology"},{"key":"1101_CR40","doi-asserted-by":"crossref","unstructured":"Tanco K, Dumlao D, Kreis R, Nguyen K, Dibaj S, Liu D, et al. Attitudes and beliefs about medical usefulness and legalization of marijuana among cancer patients in a legalized and a nonlegalized state.\u00a0J Palliat Med. 2019;22(10):1213\u201320.","DOI":"10.1089\/jpm.2019.0218"},{"issue":"2","key":"1101_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/SPC.0000000000000493","volume":"14","author":"H Meng","year":"2020","unstructured":"Meng H, Dai T, Hanlon JG, Downar J, Alibhai SMH, Clarke H. Cannabis and cannabinoids in cancer pain management. Curr Opin Support Palliat Care. 2020;14(2):87\u201393.","journal-title":"Curr Opin Support Palliat Care"},{"issue":"1","key":"1101_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s42238-021-00100-1","volume":"3","author":"JM Weisman","year":"2021","unstructured":"Weisman JM, Rodr\u00edguez M. A systematic review of medical students\u2019 and professionals\u2019 attitudes and knowledge regarding medical cannabis. J Cannabis Res. 2021;3(1):47.","journal-title":"J Cannabis Res"},{"issue":"1","key":"1101_CR43","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12954-021-00547-8","volume":"18","author":"MA Ruheel","year":"2021","unstructured":"Ruheel MA, Gomes Z, Usman S, Homayouni P, Ng JY. Facilitators and barriers to the regulation of medical cannabis: a scoping review of the peer-reviewed literature. Harm Reduct J. 2021;18(1):106.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1101_CR44","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1186\/s12913-020-05756-8","volume":"20","author":"P Hawley","year":"2020","unstructured":"Hawley P, Gobbo M, Afghari N. The impact of legalization of access to recreational cannabis on Canadian medical users with cancer. BMC Health Serv Res. 2020;20(1):977.","journal-title":"BMC Health Serv Res"},{"key":"1101_CR45","unstructured":"United States Cencus Bureau. Explore census data [Internet]. 2021 [cited 2022 May 12]. Available from: https:\/\/data.census.gov\/cedsci\/table?q=Population%20Total&tid=DECENNIALPL2020.P1&tp=false"},{"key":"1101_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116717","volume":"411","author":"EA Levinsohn","year":"2020","unstructured":"Levinsohn EA, Hill KP. Clinical uses of cannabis and cannabinoids in the United States. J Neurol Sci. 2020;411: 116717.","journal-title":"J Neurol Sci"},{"issue":"6","key":"1101_CR47","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jemermed.2020.12.028","volume":"60","author":"D Dean","year":"2021","unstructured":"Dean D, Passalacqua KD, Oh SM, Aaron C, Van Harn MG, King A. Pediatric cannabis single-substance exposures reported to the Michigan Poison Center from 2008\u20132019 after medical marijuana legalization. J Emerg Med. 2021;60(6):701\u20138.","journal-title":"J Emerg Med"},{"issue":"4","key":"1101_CR48","first-page":"472","volume":"46","author":"H Krystal","year":"2018","unstructured":"Krystal H. The misclassification of medical marijuana. J Am Acad Psychiatry Law. 2018;46(4):472\u20139.","journal-title":"J Am Acad Psychiatry Law"},{"key":"1101_CR49","doi-asserted-by":"crossref","unstructured":"\u2022\u00a0Wilkinson ST, Yarnell S, Radhakrishnan R, Ball SA, D\u2019Souza DC. Marijuana legalization: impact on physicians and public health. Annu Rev Med. 2016;67(1):453\u201366. This paper explores the contradictory arguments in support and against the legalization of cannabis.","DOI":"10.1146\/annurev-med-050214-013454"},{"key":"1101_CR50","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.copsyc.2021.03.005","volume":"38","author":"D Hasin","year":"2021","unstructured":"Hasin D, Walsh C. Trends over time in adult cannabis use: a review of recent findings. Curr Opin Psychol. 2021;38:80\u20135.","journal-title":"Curr Opin Psychol"},{"issue":"1","key":"1101_CR51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s13181-016-0552-x","volume":"13","author":"GS Wang","year":"2017","unstructured":"Wang GS. Pediatric concerns due to expanded cannabis use: unintended consequences of legalization. J Med Toxicol. 2017;13(1):99\u2013105.","journal-title":"J Med Toxicol"},{"key":"1101_CR52","doi-asserted-by":"crossref","unstructured":"Andreyeva E, Ukert B. the impact of medical marijuana laws and dispensaries on self-reported health. Forum for health economics and policy [Internet]. 2019 Dec 18 [cited 2022 Sep 22];22(2). Available from: https:\/\/www.degruyter.com\/document\/doi\/10.1515\/fhep-2019-0002\/html","DOI":"10.1515\/fhep-2019-0002"},{"issue":"1","key":"1101_CR53","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1146\/annurev-clinpsy-032816-045128","volume":"13","author":"RL Pacula","year":"2017","unstructured":"Pacula RL, Smart R. Medical marijuana and marijuana legalization. Annu Rev Clin Psychol. 2017;13(1):397\u2013419.","journal-title":"Annu Rev Clin Psychol"},{"issue":"8","key":"1101_CR54","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s11606-018-4782-2","volume":"34","author":"A Shah","year":"2019","unstructured":"Shah A, Hayes CJ, Lakkad M, Martin BC. Impact of medical marijuana legalization on opioid use, chronic opioid use, and high-risk opioid use. J GEN INTERN MED. 2019;34(8):1419\u201326.","journal-title":"J GEN INTERN MED"},{"key":"1101_CR55","unstructured":"Weinstein LC, Worster B. Medical cannabis: a guide to the clinical and legal landscapes. J Fam Pract. 2019 Sep;68(7):390;394;396;399."},{"issue":"4","key":"1101_CR56","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/pharmacy6040128","volume":"6","author":"A Karst","year":"2018","unstructured":"Karst A. Weighing the benefits and risks of medical marijuana use: a brief review. Pharmacy. 2018;6(4):128.","journal-title":"Pharmacy"},{"key":"1101_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2020.107452","volume":"112","author":"YN Alharbi","year":"2020","unstructured":"Alharbi YN. Current legal status of medical marijuana and cannabidiol in the United States. Epilepsy Behav. 2020;112: 107452.","journal-title":"Epilepsy Behav"},{"issue":"12","key":"1101_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.TPM.0000574296.65760.57","volume":"34","author":"JH Kim","year":"2019","unstructured":"Kim JH, Brown D. Medical marijuana and the patient with chronic pain. Topics in Pain Management. 2019;34(12):1\u20138.","journal-title":"Topics in Pain Management"},{"issue":"1\u20133","key":"1101_CR59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejphar.2006.11.006","volume":"556","author":"B Costa","year":"2007","unstructured":"Costa B, Trovato AE, Comelli F, Giagnoni G, Colleoni M. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Eur J Pharmacol. 2007;556(1\u20133):75\u201383.","journal-title":"Eur J Pharmacol"},{"key":"1101_CR60","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Busse JW, Wang L, Kamaleldin M, Craigie S, Riva JJ, Montoya L, et al. Opioids for chronic noncancer pain: a systematic review and meta-analysis. JAMA. 2018;320(23):2448. This meta-analysis concludes that cannabinoids are just as effective as opioids for pain relief.","DOI":"10.1001\/jama.2018.18472"},{"issue":"1","key":"1101_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02190083","volume":"240","author":"M Maurer","year":"1990","unstructured":"Maurer M, Henn V, Dittrich A, Hofmann A. Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial. Eur Arch Psychiatry Clin Nuerosci. 1990;240(1):1\u20134.","journal-title":"Eur Arch Psychiatry Clin Nuerosci"},{"issue":"3","key":"1101_CR62","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jpain.2007.10.018","volume":"9","author":"S Narang","year":"2008","unstructured":"Narang S, Gibson D, Wasan AD, Ross EL, Michna E, Nedeljkovic SS, et al. Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. J Pain. 2008;9(3):254\u201364.","journal-title":"J Pain"},{"issue":"10","key":"1101_CR63","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1080\/10826084.2017.1416408","volume":"53","author":"NL Sohler","year":"2018","unstructured":"Sohler NL, Starrels JL, Khalid L, Bachhuber MA, Arnsten JH, Nahvi S, et al. Cannabis use is associated with lower odds of prescription opioid analgesic use among HIV-infected individuals with chronic pain. Subst Use Misuse. 2018;53(10):1602\u20137.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"1101_CR64","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/cpt197518184","volume":"18","author":"R Noyes","year":"1975","unstructured":"Noyes R, Brunk SF, Avery DH, Canter A. The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clin Pharmacol Ther. 1975;18(1):84\u20139.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"1101_CR65","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jpain.2016.03.002","volume":"17","author":"KF Boehnke","year":"2016","unstructured":"Boehnke KF, Litinas E, Clauw DJ. Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. J Pain. 2016;17(6):739\u201344.","journal-title":"J Pain"},{"issue":"12","key":"1101_CR66","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1097\/AJP.0000000000000364","volume":"32","author":"S Haroutounian","year":"2016","unstructured":"Haroutounian S, Ratz Y, Ginosar Y, Furmanov K, Saifi F, Meidan R, et al. The effect of medicinal cannabis on pain and quality-of-life outcomes in chronic pain: a prospective open-label study. Clin J Pain. 2016;32(12):1036\u201343.","journal-title":"Clin J Pain"},{"key":"1101_CR67","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejim.2018.01.023","volume":"49","author":"L Bar-Lev Schleider","year":"2018","unstructured":"Bar-Lev Schleider L, Mechoulam R, Lederman V, Hilou M, Lencovsky O, Betzalel O, et al. Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer. Eur J Intern Med. 2018;49:37\u201343.","journal-title":"Eur J Intern Med"},{"issue":"7","key":"1101_CR68","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1185\/03007995.2010.483941","volume":"26","author":"KA Candiotti","year":"2010","unstructured":"Candiotti KA, Gitlin MC. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution? Curr Med Res Opin. 2010;26(7):1677\u201384.","journal-title":"Curr Med Res Opin"},{"issue":"13","key":"1101_CR69","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1503\/cmaj.071178","volume":"178","author":"T Wang","year":"2008","unstructured":"Wang T, Collet JP, Shapiro S, Ware MA. Adverse effects of medical cannabinoids: a systematic review. Can Med Assoc J. 2008;178(13):1669\u201378.","journal-title":"Can Med Assoc J"},{"issue":"4","key":"1101_CR70","doi-asserted-by":"publisher","first-page":"478.e1","DOI":"10.1016\/j.ajog.2017.05.050","volume":"217","author":"TD Metz","year":"2017","unstructured":"Metz TD, Allshouse AA, Hogue CJ, Goldenberg RL, Dudley DJ, Varner MW, et al. Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity. Am J Obstet Gynecol. 2017;217(4):478.e1-478.e8.","journal-title":"Am J Obstet Gynecol"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-023-01101-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-023-01101-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-023-01101-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T15:26:07Z","timestamp":1744212367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-023-01101-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1101"],"URL":"https:\/\/doi.org\/10.1007\/s11916-023-01101-w","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]},"assertion":[{"value":"23 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}